465 related articles for article (PubMed ID: 24898058)
21. The Role of PARPs in Inflammation-and Metabolic-Related Diseases: Molecular Mechanisms and Beyond.
Ke Y; Wang C; Zhang J; Zhong X; Wang R; Zeng X; Ba X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500199
[TBL] [Abstract][Full Text] [Related]
22. Site-specific characterization of the Asp- and Glu-ADP-ribosylated proteome.
Zhang Y; Wang J; Ding M; Yu Y
Nat Methods; 2013 Oct; 10(10):981-4. PubMed ID: 23955771
[TBL] [Abstract][Full Text] [Related]
23. RNA Regulation by Poly(ADP-Ribose) Polymerases.
Bock FJ; Todorova TT; Chang P
Mol Cell; 2015 Jun; 58(6):959-69. PubMed ID: 26091344
[TBL] [Abstract][Full Text] [Related]
24. Phosphoproteomic approach to characterize protein mono- and poly(ADP-ribosyl)ation sites from cells.
Daniels CM; Ong SE; Leung AK
J Proteome Res; 2014 Aug; 13(8):3510-22. PubMed ID: 24920161
[TBL] [Abstract][Full Text] [Related]
25. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs.
Gibson BA; Kraus WL
Nat Rev Mol Cell Biol; 2012 Jun; 13(7):411-24. PubMed ID: 22713970
[TBL] [Abstract][Full Text] [Related]
26. Are PARPs promiscuous?
Feijs KLH; Žaja R
Biosci Rep; 2022 May; 42(5):. PubMed ID: 35380161
[TBL] [Abstract][Full Text] [Related]
27. Poly(ADP-ribose): PARadigms and PARadoxes.
Bürkle A; Virág L
Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
[TBL] [Abstract][Full Text] [Related]
28. Poly (ADP-Ribose) Polymerases (PARPs) and PARP Inhibitor-Targeted Therapeutics.
Li N; Wang Y; Deng W; Lin SH
Anticancer Agents Med Chem; 2019; 19(2):206-212. PubMed ID: 30417796
[TBL] [Abstract][Full Text] [Related]
29. Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.
Frigon L; Pascal JM
Nucleic Acids Res; 2023 Dec; 51(22):12492-12507. PubMed ID: 37971310
[TBL] [Abstract][Full Text] [Related]
30. The poly(ADP-ribose) polymerases (PARPs): new roles in intracellular transport.
Abd Elmageed ZY; Naura AS; Errami Y; Zerfaoui M
Cell Signal; 2012 Jan; 24(1):1-8. PubMed ID: 21840394
[TBL] [Abstract][Full Text] [Related]
31. Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.
Mangerich A; Debiak M; Birtel M; Ponath V; Balszuweit F; Lex K; Martello R; Burckhardt-Boer W; Strobelt R; Siegert M; Thiermann H; Steinritz D; Schmidt A; Bürkle A
Toxicol Lett; 2016 Feb; 244():56-71. PubMed ID: 26383629
[TBL] [Abstract][Full Text] [Related]
32. Biochemical characterization of mono(ADP-ribosyl)ated poly(ADP-ribose) polymerase.
Mendoza-Alvarez H; Alvarez-Gonzalez R
Biochemistry; 1999 Mar; 38(13):3948-53. PubMed ID: 10194306
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites.
Altmeyer M; Messner S; Hassa PO; Fey M; Hottiger MO
Nucleic Acids Res; 2009 Jun; 37(11):3723-38. PubMed ID: 19372272
[TBL] [Abstract][Full Text] [Related]
34. ART2, a T cell surface mono-ADP-ribosyltransferase, generates extracellular poly(ADP-ribose).
Morrison AR; Moss J; Stevens LA; Evans JE; Farrell C; Merithew E; Lambright DG; Greiner DL; Mordes JP; Rossini AA; Bortell R
J Biol Chem; 2006 Nov; 281(44):33363-72. PubMed ID: 16931513
[TBL] [Abstract][Full Text] [Related]
35. Poly(ADP-ribose)--a unique natural polymer structural features, biological role and approaches to the chemical synthesis.
Drenichev MS; Mikhailov SN
Nucleosides Nucleotides Nucleic Acids; 2015; 34(4):258-76. PubMed ID: 25774719
[TBL] [Abstract][Full Text] [Related]
36. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres.
Smith S; Giriat I; Schmitt A; de Lange T
Science; 1998 Nov; 282(5393):1484-7. PubMed ID: 9822378
[TBL] [Abstract][Full Text] [Related]
37. New directions in poly(ADP-ribose) polymerase biology.
Bock FJ; Chang P
FEBS J; 2016 Nov; 283(22):4017-4031. PubMed ID: 27087568
[TBL] [Abstract][Full Text] [Related]
38. A colorimetric substrate for poly(ADP-ribose) polymerase-1, VPARP, and tankyrase-1.
Nottbohm AC; Dothager RS; Putt KS; Hoyt MT; Hergenrother PJ
Angew Chem Int Ed Engl; 2007; 46(12):2066-9. PubMed ID: 17299820
[No Abstract] [Full Text] [Related]
39. PARP inhibition: PARP1 and beyond.
Rouleau M; Patel A; Hendzel MJ; Kaufmann SH; Poirier GG
Nat Rev Cancer; 2010 Apr; 10(4):293-301. PubMed ID: 20200537
[TBL] [Abstract][Full Text] [Related]
40. PARPs and ADP-Ribosylation Come Into Focus.
Kraus WL
Mol Cell; 2015 Jun; 58(6):901. PubMed ID: 26091338
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
